Motley Fool Staff Articles
Last 50 articles...
- DFP Ecap test page
- Monday's Top News Headlines
- Friday's Top News Headlines
- Thursday's Top News Headlines
- Rupert Murdoch Doesn't Care What You Think (and That's Why He Wins)
- The Dangers of Investing With the Herd
- Wednesday's Top News Headlines
- Enterprise Inns Left Feeling Chilly as Drinkers Stay Away
- Tuesday's Top News Headlines
- Profits From Death Services Provider Dignity Rise Again
- Monday's Top News Headlines
- Baseball Cards: What's Byron Buxton Worth?
- Friday's Top News Headlines
- All-Time High for Rightmove on Record Site Traffic
- Thursday's Top News Headlines
- What Should Vodafone Group Shareholders Expect?
- 7 Free Productivity Tools
- Financial Security Looks Different to Different People
- Wednesday's Top News Headlines
- Facebook: How Much Can You Believe in Its Comeback?
- ASX Hot Stocks: Telstra, Fortescue, and Papillon
- RBA Cuts Rate by 25 Basis Points
- Tuesday's Top News Headlines
- Real-Money Stock Picks - Taylor Muckerman
- Monday's Top News Headlines
- Why Halfords Group Still Gets My Motor Running
- 1 Stock to Buy in May
- Friday's Top News Headlines
- Will Netflix Merely Prove to Be a House of Cards for Investors?
- Under Armour's Bright Future
- Thursday's Top News Headlines
- Life's Normal Until the Next Surprise Hits
- Wednesday's Top News Headlines
- Apple Shop Redirect
- Tuesday's Top News Headlines
- Caterpillar Report Redirect
- Will the New York Times Soon Make Big News?
- Why GlaxoSmithKline Is Up 24% During the Last 12 Months
- Monday's Top News Headlines
- A Fool's Eye View of ARM Holdings
- 5 Money-Saving Travel Tips
- Why I Like Fresnillo
- 4 Steps to Manage Your Desire for Instant Gratification
- Wednesday's Top News Headlines
- Tuesday's Top News Headlines
- Do You Have the Stomach to Start Buying Apple's Stock? (You Should!)
- Monday's Top News Headlines
- GlaxoSmithKline Accused of Market Abuse
- Friday's Top News Headlines
- Thursday's Top News Headlines
RSS Feed
Fool UK